Edward Stelmakh - 19 Dec 2025 Form 4/A - Amendment Insider Report for OptimizeRx Corp (OPRX)

Reporting relationship: Chief Finance & Strat Officer
Issuer ticker: OPRX
Reported as of: 19 Dec 2025
Net transaction value: -$18,752
SEC form: 4/A - Amendment
Accepted by SEC: 23 Dec 2025, 14:23:07 UTC
Original report date: 22 Dec 2025
Prior SEC filing: 07 Oct 2025
Next SEC filing: 23 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Marion Odence-Ford, by Power of Attorney

Key filing fact

Edward Stelmakh filed Form 4/A - Amendment for OptimizeRx Corp (OPRX) on 23 Dec 2025.

Key facts

This page summarizes Edward Stelmakh's Form 4/A - Amendment filing for OptimizeRx Corp (OPRX).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 23 Dec 2025, 14:23.

Change

Previous filing in this sequence was filed on 07 Oct 2025.
Current net transaction value: -$18,752.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001887046 Primary reporting owner

Stelmakh Edward

Relationship: Chief Finance & Strat Officer
Address: C/O OPTIMIZERX CORPORATION, 260 CHARLES STREET, SUITE 302, WALTHAM
Signature: /s/ Marion Odence-Ford, by Power of Attorney
Signature date: 23 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OPRX transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +5,237
Change %: +4.3%
Price: $0.000000
Shares after: 128,218
Date: 19 Dec 2025
Ownership: Direct
Footnotes: F1

OPRX transaction

Common Stock

Tax liability

Transaction value: $18,752
Shares: -1,388
Change %: -1.1%
Price: $13.51
Shares after: 126,830
Date: 19 Dec 2025
Ownership: Direct
Footnotes: F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OPRX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -5,237
Change %: -50%
Price: $0.000000
Shares after: 5,237
Date: 19 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,237
Exercise price
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Restricted stock units convert into common stock on a one-for-one basis.

Footnote F2

This Form 4/A is filed to correct the transaction code in Table I. The disposition of 1,388 shares previously reported as Transaction Code S should have been reported as Transaction Code F to reflect shares withheld by the issuer to satisfy tax withholding obligations.

Footnote F3

These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.

Footnote F4

The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date.

SEC remarks

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.